The downregulation of miR‐451 was responsible for the increase in multidrug resistance protein 1 (MDR1) in FLT3‐internal tandem duplication+ (ITD) AML, and as such contributed to the poor therapeutic response [25] seen in these patients. This evidence concerns the gene FLT3 and acute myeloid leukemia.